243 related articles for article (PubMed ID: 18356147)
1. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
3. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
4. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma.
Ho CM; Lai HC; Huang SH; Chien TY; Lin MC; Chang SF
Eur J Clin Invest; 2010 Apr; 40(4):310-8. PubMed ID: 20486992
[TBL] [Abstract][Full Text] [Related]
6. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
7. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.
Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD
Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
15. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
17. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
18. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
[TBL] [Abstract][Full Text] [Related]
19. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]